Biomarker-Driven Treatment Strategy in High-Risk Large B-Cell Lymphoma: Final Results of a Nordic Phase 2 Study

Sirpa Leppä; JM Jorgensen; Marja-Liisa Karjalainen-Lindsberg; Klaus Beiske; Mette Pedersen; Kristina Drott; Annika Pasanen; Kristiina Karihtala; Susanna Mannisto; Leo Meriranta; Bente Wold; Marianne Brodtkorb; Unn Merete Fagerli; Thomas S. Larsen; Lars  Munksgaard; Kaisa Sunela; Oysten Fluge; S. Jyrkkiö; Peter de Nully Brown; H Holte

Biomarker-Driven Treatment Strategy in High-Risk Large B-Cell Lymphoma: Final Results of a Nordic Phase 2 Study

Sirpa Leppä, JM Jorgensen, Marja-Liisa Karjalainen-Lindsberg, Klaus Beiske, Mette Pedersen, Kristina Drott, Annika Pasanen, Kristiina Karihtala, Susanna Mannisto, Leo Meriranta, Bente Wold, Marianne Brodtkorb, Unn Merete Fagerli, Thomas S. Larsen, Lars Munksgaard, Kaisa Sunela, Oysten Fluge, S. Jyrkkiö, Peter de Nully Brown, H Holte

Research output: Other conference contribution › Abstract › Scientific

Original language	English
Publication status	Published - 12 Dec 2022
Publication type	Not Eligible
Event	ASH 2022 - , United States Duration: 11 Dec 2022 → 13 Dec 2022 https://www.hematology.org/meetings/annual-meeting/programs/scientific-spotlight

Conference

Conference	ASH 2022
Country/Territory	United States
Period	11/12/22 → 13/12/22
Internet address	https://www.hematology.org/meetings/annual-meeting/programs/scientific-spotlight

Keywords

biomarker
high-grade lymphoma

Access to Document

https://ash.confex.com/ash/2022/webprogram/Paper158183.html

Cite this

Leppä, S., Jorgensen, JM., Karjalainen-Lindsberg, M.-L., Beiske, K., Pedersen, M., Drott, K., Pasanen, A., Karihtala, K., Mannisto, S., Meriranta, L., Wold, B., Brodtkorb, M., Fagerli, U. M., Larsen, T. S., Munksgaard, L., Sunela, K., Fluge, O., Jyrkkiö, S., de Nully Brown, P., & Holte, H. (2022). Biomarker-Driven Treatment Strategy in High-Risk Large B-Cell Lymphoma: Final Results of a Nordic Phase 2 Study. Abstract from ASH 2022, United States. https://ash.confex.com/ash/2022/webprogram/Paper158183.html

@conference{be79b9e5b9704e6c9ae40c560d4e85f0,

title = "Biomarker-Driven Treatment Strategy in High-Risk Large B-Cell Lymphoma: Final Results of a Nordic Phase 2 Study",

keywords = "biomarker, high-grade lymphoma",

author = "Sirpa Lepp{\"a} and JM Jorgensen and Marja-Liisa Karjalainen-Lindsberg and Klaus Beiske and Mette Pedersen and Kristina Drott and Annika Pasanen and Kristiina Karihtala and Susanna Mannisto and Leo Meriranta and Bente Wold and Marianne Brodtkorb and Fagerli, {Unn Merete} and Larsen, {Thomas S.} and Lars Munksgaard and Kaisa Sunela and Oysten Fluge and S. Jyrkki{\"o} and {de Nully Brown}, Peter and H Holte",

year = "2022",

month = dec,

day = "12",

language = "English",

note = "ASH 2022 ; Conference date: 11-12-2022 Through 13-12-2022",

url = "https://www.hematology.org/meetings/annual-meeting/programs/scientific-spotlight",

}

Leppä, S, Jorgensen, JM, Karjalainen-Lindsberg, M-L, Beiske, K, Pedersen, M, Drott, K, Pasanen, A, Karihtala, K, Mannisto, S, Meriranta, L, Wold, B, Brodtkorb, M, Fagerli, UM, Larsen, TS, Munksgaard, L, Sunela, K, Fluge, O, Jyrkkiö, S, de Nully Brown, P & Holte, H 2022, 'Biomarker-Driven Treatment Strategy in High-Risk Large B-Cell Lymphoma: Final Results of a Nordic Phase 2 Study', ASH 2022, United States, 11/12/22 - 13/12/22. <https://ash.confex.com/ash/2022/webprogram/Paper158183.html>

TY - CONF

T1 - Biomarker-Driven Treatment Strategy in High-Risk Large B-Cell Lymphoma

T2 - ASH 2022

AU - Leppä, Sirpa

AU - Jorgensen, JM

AU - Karjalainen-Lindsberg, Marja-Liisa

AU - Beiske, Klaus

AU - Pedersen, Mette

AU - Drott, Kristina

AU - Pasanen, Annika

AU - Karihtala, Kristiina

AU - Mannisto, Susanna

AU - Meriranta, Leo

AU - Wold, Bente

AU - Brodtkorb, Marianne

AU - Fagerli, Unn Merete

AU - Larsen, Thomas S.

AU - Munksgaard, Lars

AU - Sunela, Kaisa

AU - Fluge, Oysten

AU - Jyrkkiö, S.

AU - de Nully Brown, Peter

AU - Holte, H

PY - 2022/12/12

Y1 - 2022/12/12

KW - biomarker

KW - high-grade lymphoma

M3 - Abstract

Y2 - 11 December 2022 through 13 December 2022

ER -